Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

- The article is written by Madison Muller, Robert Langreth, and Bloomberg. - The article discusses the possibility of pharmaceutical companies gaining billions from Covid-19 vaccines. - Companies like Pfizer (PFE), Moderna (MRNA), and AstraZeneca (AZN) are mentioned in the article. - Pfizer and Moderna are projected to profit significantly from their vaccines. - Pfizer's stock price has already risen due to vaccine distribution. - The article highlights concerns about pricing and access to vaccines for lower-income countries. - The pharmaceutical industry's profits from Covid-19 vaccines are expected to be substantial.